Forum |  HardWare.fr | News | Articles | PC | S'identifier | S'inscrire | Shop Recherche
2661 connectés 

 
 

Sujet(s) à lire :
    - COVID-19 : PRÊTS POUR LA 4e VAGUE ?
    - [COVID-19]- Folding@Home - Aidez la recherche de chez vous
    - [MASQUES & AUTOTESTS] Le topic des accessoires de la pandémie.
    - Covid-19 - Médecine, biologie, épidémiologie
    - COVID-19 - Effet de bord des vaccins
 

 Mot :   Pseudo :  
  Aller à la page :
 
 Page :   1  2  3  4  5  ..  12741  12742  12743  ..  25261  25262  25263  25264  25265  25266
Page Suivante
Page Précédente
Bas de page 
Auteur Sujet :

COVID-19 - sa vie, son œuvre

n°61518665
fred_div91
Posté le 04-12-2020 à 19:56:42  profilanswer
 

Reprise du message précédent :

Requiem a écrit :

 

+1 mais c'est pas nouveau

 

T'es pas obligé de rester en France hein ... Le monde est vaste.

Message cité 2 fois
Message édité par fred_div91 le 04-12-2020 à 19:57:05
mood
Publicité
Posté le 04-12-2020 à 19:56:42  profilanswer
 

n°61518672
fazero
Salut c'est Ralph
Posté le 04-12-2020 à 19:57:21  profilanswer
 

sundae cent a écrit :

Sérieux, on peut pas autoban ceux qui citent du Raoult en décembre 2020 ? Moi, je peux poster des photos de caca ou des posts vantant la scientologie, par exemple, sinon ?


Je sais pas, ça permet quand même de repérer les gogoles de façon très efficace


---------------
Agent immobilier sur Paris 16
n°61518673
baliste_ti​tan
Posté le 04-12-2020 à 19:57:22  profilanswer
 

L’étude la plus citée sur ce forum est celle de Merah et Al.
Ca donne le niveau

Message cité 2 fois
n°61518675
Marcel Pit​ou
Posté le 04-12-2020 à 19:57:53  profilanswer
 

Tammuz a écrit :


 
A voir la base de fans qu'il a réussi à se constituer en racontant n'importe quoi, c'est au contraire plutôt la communication qui est son point fort.   [:somberlain-19]


 
Perso, je pense que c'est un très bon scientifique..., mais qui a fait justement l'erreur d'utiliser les réseaux sociaux (youtube, etc...), en faisant ça..., il s'est créer une sorte de secte autour de lui, et au finale, ça lui as été néfaste pour sa réputation.

Message cité 5 fois
n°61518681
Tammuz
Posté le 04-12-2020 à 19:58:22  profilanswer
 

baliste_titan a écrit :

L’étude la plus citée sur ce forum est celle de Merah et Al.
Ca donne le niveau


 
Mohammed Merah ?    [:smileyps:4]

Message cité 2 fois

---------------
"Que Dieu vous garde du feu, du couteau, de la littérature contemporaine et de la rancune des mauvais morts." Léon Bloy
n°61518682
Amenorrhee​ suspecte
Gauchiste
Posté le 04-12-2020 à 19:58:27  profilanswer
 

Marcel Pitou a écrit :


 
Perso, je pense que c'est un très bon scientifique..., mais qui a fait justement l'erreur d'utiliser les réseaux sociaux (youtube, etc...), en faisant ça..., il s'est créer une sorte de secte autour de lui, et au finale, ça lui as été néfaste pour sa réputation.


Mais ça lui convient visiblement très bien

Message cité 1 fois

---------------
"Le bègue, je vais le crever" - Président Nicolas Sarkozy
n°61518692
fazero
Salut c'est Ralph
Posté le 04-12-2020 à 19:59:10  profilanswer
 

Tammuz a écrit :

 

Mohammed Merah ? [:smileyps:4]


Et al
Il n'était donc pas seul  [:alain hiramoux:5]


---------------
Agent immobilier sur Paris 16
n°61518694
daouar
Shree Uvasaggaharam Stotra
Posté le 04-12-2020 à 19:59:23  profilanswer
 

Marcel Pitou a écrit :


 
Perso, je pense que c'est un très bon scientifique..., mais qui a fait justement l'erreur d'utiliser les réseaux sociaux (youtube, etc...), en faisant ça..., il s'est créer une sorte de secte autour de lui, et au finale, ça lui as été néfaste pour sa réputation.


 
Alors que s'il avait fait un vrai étude sans faire de bruit dès le début :o


---------------
Ducouïte : maladie consistant à parsemer ses posts de "du coup" et "pour le coup" | TU des moteurs de recherche !
n°61518696
sundae cen​t
Posté le 04-12-2020 à 19:59:32  profilanswer
 

C'est quand même assez dingue l'obscurantisme niveau sciences dans notre pays quand, à côté, on est supposé être assez progressiste sur le sociétal, laïc et tout le toutim.  
 
Y a un truc qui a merdé à un moment. Probablement d'avoir confondu la tolérance et le baissage de froc devant tout pour pas froisser ces minorités.

Message cité 1 fois
n°61518697
Tammuz
Posté le 04-12-2020 à 19:59:37  profilanswer
 

Marcel Pitou a écrit :


 
Perso, je pense que c'est un très bon scientifique..., mais qui a fait justement l'erreur d'utiliser les réseaux sociaux (youtube, etc...), en faisant ça..., il s'est créer une sorte de secte autour de lui, et au finale, ça lui as été néfaste pour sa réputation.


 
Son erreur, ce n'est pas d'avoir utilisé les réseaux sociaux, mais de les avoir utilisés pour raconter n'importe quoi.   [:tammuz:3]


---------------
"Que Dieu vous garde du feu, du couteau, de la littérature contemporaine et de la rancune des mauvais morts." Léon Bloy
mood
Publicité
Posté le 04-12-2020 à 19:59:37  profilanswer
 

n°61518698
Killall-9
+on&2foo...
Posté le 04-12-2020 à 19:59:46  profilanswer
 

Marcel Pitou a écrit :


 
Ça se discute...
 
Le pays d'idiots va perdre un grand nombre de personnes "vieille, ou malades...", mais avec le temps et les générations qui se succèdent, il pourrait s'auto-immuniser "naturellement"..., le pays des intelligents va s'injecter un vaccin tout les ans dans le bras, et porter un putain de masque...  :o


Au vu des connaissance actuelles, l'immunité des premiers contaminés va avoir disparu avant d'avoir une herd immunity tangible.

n°61518699
boumbo
3xpl0its
Posté le 04-12-2020 à 19:59:59  profilanswer
 

[:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]
 
j’ai fait une sausalito :o

Message cité 2 fois
Message édité par boumbo le 04-12-2020 à 20:00:24
n°61518700
@micka92
Posté le 04-12-2020 à 20:00:00  profilanswer
 

[:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]

n°61518701
sausalito7​5
Posté le 04-12-2020 à 20:00:00  profilanswer
 

[:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]

n°61518702
La Monne
Tu dois rompre.
Posté le 04-12-2020 à 20:00:12  profilanswer
 

Marcel Pitou a écrit :

 

Perso, je pense que c'est un très bon scientifique..., mais qui a fait justement l'erreur d'utiliser les réseaux sociaux (youtube, etc...), en faisant ça..., il s'est créer une sorte de secte autour de lui, et au finale, ça lui as été néfaste pour sa réputation.


Ce qui a été néfaste c'est de vouloir nourrir son ego en étant convaincu qu'il a trouvé un traitement sur la base d'un essai faussé.
Les réseaux sociaux, c'est juste l'éclairage sur cela


---------------
Lu et approuvé.
n°61518703
AzR3L
Posté le 04-12-2020 à 20:00:16  profilanswer
 

Requiem a écrit :


 
+1 mais c'est pas nouveau


 
CE qui me sidère le plus, c'est j'ai peur du COVID, mais encore plus du VACCIN.. MA grand mère qui a un cancer donc logiquement à fort risque et qui va reprendre sa chimio  :( , ne veut pas se faire vacciner.. :pfff:  car elle a peur des  conséquences potentielles du VACCIN

Message cité 1 fois
Message édité par AzR3L le 04-12-2020 à 20:01:34
n°61518705
viniw
geek repenti
Posté le 04-12-2020 à 20:00:19  profilanswer
 

[:lafroussedanstonfrog:3][:lafroussedanstonfrog:3][:lafroussedanstonfrog:3]

n°61518706
baliste_ti​tan
Posté le 04-12-2020 à 20:00:21  profilanswer
 

Tammuz a écrit :


 
Mohammed Merah ?    [:smileyps:4]


 
Oui
Des maladies tropicales services tropicaux

n°61518712
orodreths
Donkey pue du cul
Posté le 04-12-2020 à 20:00:42  profilanswer
 

Tolor a écrit :

[:soulafa] Comme chaque soir, les chiffres du jour pour la France, avec les données de sante publique France :
 
Hôpitaux
Décès : 284 (hier : 326 / J-7 : 396 / moyenne sur 7j de 301)
Réa : 165 (hier : 184 / J-7 : 206 / moyenne sur 7j de 166, Rt de 0,8)
Hospitalisés : 1 400 (hier : 1 450 / J-7 : 1 471 / moyenne sur 7j de 1 223, Rt de 0,88)
Total réa : 3 283 (hier : 3 415 / J-7 : 3 871) soit une baisse de 132
Total hospitalisation : 26 283 (hier : 26 675 / J-7 : 28 620) soit une baisse de 392
 
Baisse assez importante des totaux. Les Rt augmentent encore un peu (+0,01 pour les réa, +0,03 pour les hospi
On devrait passer la barre des 3000 mardi ou mercredi prochain
 
Pour les chiffres régionaux, ça stagne un peu au niveau des hospi, ça baisse au niveau réa et décès
https://i.imgur.com/fTeRIjB.png
 
Concernant l'occupation en réa, Martinique et Corse montent respectivement de 2 et 1
https://i.imgur.com/9KXth8P.png
 
Tests
Ajout des chiffres du mercredi 1er décembre, le Rt augmente à nouveau et repasse les 0,8. L'incidence et la positivité baisse
Si on continue comme ça, l'objectif des 5k ne sera pas atteint le 15
https://i.imgur.com/rfq2ag9.png
 
Pour les régions,
https://i.imgur.com/09zInSz.png
 
Et les départements, 11 départements sont au-dessus de 1
https://i.imgur.com/ThWuEQU.png
 
Passage aux urgences
Le Rt remonte à 0,85
 
Rt
https://i.imgur.com/QadLchZ.png
 
#SUIVICOVID


 
Pas étonnant que ça se stabilise et ainsi le Rt remonte on est à 8k cas/ jours de moyenne qui aurait dit ça fin octobre. Le plus important est maintenant que ça se stabilise à ce niveau raisonnable.

Message cité 1 fois

---------------
#TeamFirst
n°61518713
AzR3L
Posté le 04-12-2020 à 20:00:45  profilanswer
 

boumbo a écrit :

[:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]


 
 
[:bararhum:1]

n°61518715
@micka92
Posté le 04-12-2020 à 20:01:00  profilanswer
 

[:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]

n°61518716
totsukaba
Code Quantum
Posté le 04-12-2020 à 20:01:09  profilanswer
 

Tolor a écrit :

[:soulafa] Comme chaque soir, les chiffres du jour pour la France, avec les données de sante publique France :
 
Hôpitaux
Décès : 284 (hier : 326 / J-7 : 396 / moyenne sur 7j de 301)
Réa : 165 (hier : 184 / J-7 : 206 / moyenne sur 7j de 166, Rt de 0,8)
Hospitalisés : 1 400 (hier : 1 450 / J-7 : 1 471 / moyenne sur 7j de 1 223, Rt de 0,88)
Total réa : 3 283 (hier : 3 415 / J-7 : 3 871) soit une baisse de 132
Total hospitalisation : 26 283 (hier : 26 675 / J-7 : 28 620) soit une baisse de 392
 
Baisse assez importante des totaux. Les Rt augmentent encore un peu (+0,01 pour les réa, +0,03 pour les hospi
On devrait passer la barre des 3000 mardi ou mercredi prochain
 
Pour les chiffres régionaux, ça stagne un peu au niveau des hospi, ça baisse au niveau réa et décès
https://i.imgur.com/fTeRIjB.png
 
Concernant l'occupation en réa, Martinique et Corse montent respectivement de 2 et 1
https://i.imgur.com/9KXth8P.png
 
Tests
Ajout des chiffres du mercredi 1er décembre, le Rt augmente à nouveau et repasse les 0,8. L'incidence et la positivité baisse
Si on continue comme ça, l'objectif des 5k ne sera pas atteint le 15
https://i.imgur.com/rfq2ag9.png
 
Pour les régions,
https://i.imgur.com/09zInSz.png
 
Et les départements, 11 départements sont au-dessus de 1
https://i.imgur.com/ThWuEQU.png
 
Passage aux urgences
Le Rt remonte à 0,85
 
Rt
https://i.imgur.com/QadLchZ.png
 
#SUIVICOVID


 
Bordel de merde, il y aura qu'a reprendre les chiffres d'avant le second confinement et comparer avec quand le Rt repassera au dessus de 1, et on saura quand a peu près sera le troisième confinement.


---------------
flickr
n°61518717
Profil sup​primé
Posté le 04-12-2020 à 20:01:11  answer
 

Le contenu de ce message a été effacé par son auteur

Message cité 1 fois
n°61518724
@micka92
Posté le 04-12-2020 à 20:02:00  profilanswer
 

[:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]

n°61518725
sundae cen​t
Posté le 04-12-2020 à 20:02:00  profilanswer
 

Amenorrhee suspecte a écrit :


Mais ça lui convient visiblement très bien


Son IHU va devenir un véritable désastre en terme de réputation. Apparemment, y a de vrais scientifiques qui bossent dedans, un peu dissidents vis à vis de la mafia, mais ils ferment leur clapet. Imaginez un interne en médecine à qui il reste plus que ce choix de stage. Moi, je préfèrerais ne pas y aller et me faire invalider.

Message cité 3 fois
n°61518729
Tchin
Posté le 04-12-2020 à 20:02:15  profilanswer
 

sausalito75 a écrit :


Oui ils sont inclus (9000 et 2000 en gros pour aujourd'hui).
+284 décès, tant qu'on y est


 
Oui on voit le détail, il représente 18% donc. Il me semblait que au début ca disait que les antigéniques représentaient 10% des positifs.
Et il me semblait aussi que tous les antigéniques n'étaient pas remontés "au début" car la plateforme pour les pharmacies n'était pas prête. Est-ce que la plate forme est prête et donc plus de tests antigénique sont remontés maintenant (et donc logique que ca représente un plus gros % et que la baisse soit moins marquée le temps que tout s'équilibre)?  
Ou alors tjs pas de plateforme de prete? Et là c'est pas bon signe

n°61518731
karaya
Posté le 04-12-2020 à 20:02:18  profilanswer
 

epsiloncentaury a écrit :

 

VIDEO-Is hydroxychloroquine effective for COVID-19? A video history of the 152 HCQ studies to date

 


Citation :

References
1.
Abd-Elsalam et al., American Journal of Tropical Medicine and Hygiene, 10.4269/ajtmh.20-0873, Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study, https://www.ajtmh.org/content/journ [...] h.20-0873.
2.
Abdulrahman et al., medRxiv, doi:10.1101/2020.11.25.20234914, The efficacy and safety of hydroxychloroquine in COVID19 patients : a multicenter national retrospective cohort , https://www.medrxiv.org/content/10. [...] 0234914v1.
3.
Abella et al., JAMA Internal Medicine, doi:doi:10.1001/jamainternmed.2020.6319, Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers, https://jamanetwork.com/journals/j. [...] e/2771265.
4.
AFP, India backs hydroxychloroquine for virus prevention, https://www.msn.com/en-ph/news/wor. [...] ?ocid=st2.
5.
AfricaFeeds, Kenya approve the use of Chloroquine to treat COVID-19 patients, https://africafeeds.com/2020/04/01. [...] patients/.
6.
Africanews, Coronavirus patients on chloroquine heal faster - Senegalese medic, https://www.africanews.com/2020/04. [...] se-medic/.
7.
Afrik.com, Edouard Philippe emporté par le Covid, Didier Raoult, l’hydroxychloroquine et le… remdésivir, https://www.afrik.com/edouard-phil. [...] emdesivir.
8.
Águila-Gordo et al., Revista Española de Geriatría y Gerontología, doi:10.1016/j.regg.2020.09.006, Mortality and associated prognostic factors in elderly and very elderly hospitalized patients with respiratory disease COVID-19, https://www.sciencedirect.com/scien [...] X20301748.
9.
Al Arabia, Bahrain among first countries to use Hydroxychloroquine to treat coronavirus, https://english.alarabiya.net/en/N. [...] ronavirus.
10.
Al-bab, Covid-19: Algeria and Morocco continue using chloroquine despite concerns, https://al-bab.com/blog/2020/05/co. [...] -concerns.
11.
Alamdari et al., Tohoku J. Exp. Med., 2020, 252, 73-84, doi:10.1620/tjem.252.73, Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran, https://www.jstage.jst.go.jp/artic. [...] -char/ja/.
12.
Alberici et al., Kidney Int., 98:1, 20-26, July 1, 2020, doi:10.1016/j.kint.2020.04.030 (preprint 5/10), A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection, https://www.kidney-international.o. [...] /fulltext.
13.
Almazrou et al., Saudi Pharmaceutical Journal, doi:10.1016/j.jsps.2020.09.019, Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study, https://www.sciencedirect.com/scien [...] 420302334.
14.
Altman, D., BMJ, doi:10.1136/bmj.d2304, How to obtain the P value from a confidence interval, https://www.bmj.com/content/343/bmj.d2304.
15.
Altman (B) et al., BMJ, doi:10.1136/bmj.d2090, How to obtain the confidence interval from a P value, https://www.bmj.com/content/343/bmj.d2090.
16.
An et al., medRxiv, doi:10.1101/2020.07.04.20146548, Treatment Response to Hydroxychloroquine and Antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea, https://www.medrxiv.org/content/10. [...] 0146548v1.
17.
Anadolu Agency, Nigeria goes on with hydroxychloroquine clinical trial, https://www.aa.com.tr/en/africa/ni. [...] s/1854814.
18.
Anadolu Agency (B), Cuba: Early hydroxychloroquine potent against COVID-19, https://www.aa.com.tr/en/americas/. [...] 9/1905650.
19.
Anglemyer et al., Cochrane Database of Systematic Reviews 2014, Issue 4, doi:10.1002/14651858.MR000034.pub2, Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials, https://www.cochranelibrary.com/cd. [...] pub2/full.
20.
Annie et al., Pharmacotherapy, doi:10.1002/phar.2467, Hydroxychloroquine in hospitalized COVID‐19 patients: Real world experience assessing mortality, https://accpjournals.onlinelibrary. [...] phar.2467.
21.
Aparisi et al., medRxiv, doi:10.1101/2020.10.06.20207092, Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19, https://www.medrxiv.org/content/10. [...] 0207092v1.
22.
Archyde, China approves chloroquine (instead of hydroxychloroquine) against covid-19, https://www.archyde.com/china-appr. [...] covid-19/.
23.
Arleo et al., medRxiv, doi:10.1101/2020.10.26.20219154, Clinical Course and Outcomes of coronavirus disease 2019 (COVID-19) in Rheumatic Disease Patients on Immunosuppression: A case Cohort Study at a Single Center with a Significantly Diverse Population, https://www.medrxiv.org/content/10. [...] 0219154v1.
24.
Arshad et al., Int. J. Infect. Dis., July 1 2020, doi:10.1016/j.ijid.2020.06.099, Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19, https://www.ijidonline.com/article/ [...] /fulltext.
25.
Ashinyo et al., Pan African Medical Journal, 37:1, doi:10.11604/pamj.supp.2020.37.1.25718, Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study, https://www.panafrican-med-journal. [...] 1/9/full/.
26.
Ashraf et al., medRxiv doi:10.1101/2020.04.20.20072421.t, COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes, https://www.researchgate.net/publi. [...] _outcomes.
27.
Axfors et al., medRxiv, doi:10.1101/2020.09.16.20194571, Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials, https://www.medrxiv.org/content/10. [...] 0194571v1.
28.
Ayerbe et al., Internal and Emergency Medicine, doi:0.1007/s11739-020-02505-x, The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients, https://link.springer.com/article/1 [...] 0-02505-x.
29.
Barbosa et al., Preprint, Clinical outcomes of hydroxychloroquine in hospitalized patients with COVID-19: a quasi-randomized comparative study, https://www.sefq.es/_pdfs/NEJM_Hydroxychlorquine.pdf.
30.
Barron's, Hydroxychloroquine: A Drug Dividing The World, https://www.barrons.com/news/hydro. [...] 591006809.
31.
Barron's (B), Amid Global Controversy, Greece Moves Forward With Chloroquine, https://www.barrons.com/news/amid-. [...] 591781707.
32.
BBC, Coronavirus: How Turkey took control of Covid-19 emergency, https://www.bbc.com/news/world-europe-52831017.
33.
Behera et al., medRxiv, doi:10.1101/2020.10.29.20222661v1, Role of ivermectin in the prevention of COVID-19 infection among healthcare workers in India: A matched case-control study, https://www.medrxiv.org/content/10. [...] 0222661v1.
34.
Belayneh, A., Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation, https://www.dovepress.com/off-labe. [...] icle-RRTM.
35.
Berenguer et al., Clinical Microbiology and Infection, doi:10.1016/j.cmi.2020.07.024, Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain, https://www.clinicalmicrobiologyan. [...] /fulltext.
36.
Bernaola et al., medRxiv, doi:10.1101/2020.07.17.20155960, Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in Madrid, https://www.medrxiv.org/content/10. [...] 0155960v1.
37.
Berry et al., SSRN, Berry, doi:10.2139/ssrn.3707327., Unfavorable Hydroxychloroquine COVID-19 Research Associated with Authors Having a History of Political Party Donations, https://papers.ssrn.com/sol3/papers [...] d=3707327.
38.
Bhattacharya et al., medRxix, doi:10.1101/2020.06.09.20116806, Pre exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers, https://www.medrxiv.org/content/10. [...] 0116806v1.
39.
Bianet, Turkey begins distributing hydroxychloroquine to homes in capital city amid bed shortage, https://bianet.org/english/health/. [...] -shortage.
40.
Boari et al, Biosci. Rep., doi:10.1042/BSR20203455, Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study, https://portlandpress.com/bioscire. [...] 55/226985.
41.
Boulware, D., Comments regarding paper rejection, https://twitter.com/boulware_dr/sta [...] 884205570.
42.
Boulware (B) et al., NEJM, June 3 2020, doi:10.1056/NEJMoa2016638, A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19, https://www.nejm.org/doi/full/10.1056/NEJMoa2016638.
43.
Bousquet et al., Aging, 12:12, 11306-11313, doi:10.18632/aging.103583, ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19, https://www.aging-us.com/article/103583/text.
44.
Budhiraja et al., medRxiv, doi:10.1101/2020.11.16.20232223, Clinical Profile of First 1000 COVID-19 Cases Admitted at Tertiary Care Hospitals and the Correlates of their Mortality: An Indian Experience, https://www.medrxiv.org/content/10. [...] 0232223v1.
45.
Cadegiani et al., medRxiv, doi:10.1101/2020.10.31.20223883, Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients, https://www.medrxiv.org/content/10. [...] 0223883v1.
46.
Capsoni et al., Research Square, doi:10.21203/rs.3.rs-113418/v1, CPAP Treatment In COVID-19 Patients: A Retrospective Observational Study In The Emergency Department, https://www.researchsquare.com/article/rs-113418/v1.
47.
Cassione et al., Annals of the Rheumatic Diseases, doi:10.1136/annrheumdis-2020-217717, COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine, https://ard.bmj.com/content/early/. [...] 7717.info.
48.
Catteau et al., Int. J. Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.106144, Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants, https://www.sciencedirect.com/scie. [...] 920303423.
49.
Cavalcanti et al., NEJM, July 23, 2020, doi:10.1056/NEJMoa201901, Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19, https://www.nejm.org/doi/full/10.1056/NEJMoa2019014.
50.
CBS News, Turkey claims success treating virus with drug touted by Trump, https://www.msn.com/en-au/news/wor. [...] -BB13oMXS.
51.
Challenge, Coronavirus : ce que le Maroc a réussi, https://www.challenge.ma/coronaviru [...] i-144484/.
52.
Chatterjee et al., Indian J. Med. Res., June 20, 2020, doi:10.4103/ijmr.IJMR_2234_20, Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19, http://www.ijmr.org.in/preprintarticle.asp?id=285520.
53.
Chen et al., medRxiv, doi:10.1101/2020.06.19.20136093, Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study, https://www.medrxiv.org/content/10. [...] 0136093v1.
54.
Chen (B) et al., medRxiv, doi:10.1101/2020.07.08.20148841v1, A Multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate Coronavirus disease 2019 (COVID-19), https://www.medrxiv.org/content/10. [...] 0148841v1.
55.
Chen (C) et al., medRxiv, doi:10.1101/2020.07.08.20148841v1, A Multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate Coronavirus disease 2019 (COVID-19), .
56.
Chen (D) et al., medRxiv doi:10.1101/2020.03.22.20040758, Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial, https://www.medrxiv.org/content/10. [...] 0040758v3.
57.
Chen (E) et al., J. Zhejiang University (Med Sci), doi:10.3785/j.issn.1008-9292.2020.03.03, A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19), http://www.zjujournals.com/med/EN/ [...] &id=41137.
58.
Choi et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2020.10.062, Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study, https://www.sciencedirect.com/scien [...] 220322669.
59.
Coll et al., American Journal of Transplantation, doi:10.1111/ajt.16369, Covid‐19 in transplant recipients: the spanish experience, https://onlinelibrary.wiley.com/doi [...] ajt.16369.
60.
Concato et al., NEJM, 342:1887-1892, doi:10.1056/NEJM200006223422507, https://www.nejm.org/doi/full/10.10 [...] 223422507.
61.
Cravedi et al., American Journal of Transplantation, doi:10.1111/ajt.16185, COVID‐19 and kidney transplantation: Results from the TANGO International Transplant Consortium, https://onlinelibrary.wiley.com/doi [...] ajt.16185.
62.
D'Arminio Monforte et al., Int. J. Infectious Diseases, doi:10.1016/j.ijid.2020.07.056, Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?, https://www.ijidonline.com/article/ [...] /fulltext.
63.
Davido et al., Int. J. Antimicrobial Agents, 2020, doi:10.1016/j.ijantimicag.2020.106129, Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time, https://www.sciencedirect.com/scien [...] 920303125.
64.
de la Iglesia et al., medRxiv, doi:10.1101/2020.08.31.20185314, Hydroxicloroquine for pre-exposure prophyylaxis for SARS-CoV-2, https://www.medrxiv.org/content/10. [...] 0185314v1.
65.
Deaton et al., Social Science & Medicine, 210, doi:10.1016/j.socscimed.2017.12.005, Understanding and misunderstanding randomized controlled trials, https://www.sciencedirect.com/scien [...] 617307359.
66.
Deng, H., PyMeta, Python module for meta-analysis, http://www.pymeta.com/.
67.
Derwand et al., International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.106214 (preprint 7/3), COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study, https://www.sciencedirect.com/scien [...] 920304258.
68.
Dhibar et al., International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.106224, Post Exposure Prophylaxis with Hydroxychloroquine (HCQ) for the Prevention of COVID-19, a Myth or a Reality? The PEP-CQ Study, https://www.sciencedirect.com/scien [...] 920304350.
69.
Di Castelnuovo et al., European J. Internal Medicine, doi:10.1016/j.ejim.2020.08.019, Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study, https://www.sciencedirect.com/scie. [...] 520303356.
70.
DISCOVERY Trial, DISCOVERY Trial Preliminary Results, https://twitter.com/raoult_didier/s [...] 167529472.
71.
Dr. Goldin, Summary of HCQ usage in India from an MD in India, https://www.facebook.com/groups/hy. [...] 93560817/.
72.
Dubee et al., medRxiv, doi:10.1101/2020.10.19.20214940, A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19, https://www.medrxiv.org/content/10. [...] 0214940v1.
73.
Dubernet et al., J. Global Antimicrobial Resistance, doi:10.1016/j.jgar.2020.08.001, A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island, https://www.sciencedirect.com/scien [...] 52030206X.
74.
Efecto Cocuyo, Venezuela empieza a usar la cloroquina para tratar COVID-19, anuncia Jorge Rodríguez, https://efectococuyo.com/coronavir. [...] odriguez/.
75.
Esper et al., Prevent Senior Institute, São Paulo, Brazil, Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine, https://www.dropbox.com/s/5qm58cd4. [...] final.pdf.
76.
Expats.cz, Czech Health Ministry permits temporary use of hydroxychloroquine to treat COVID-19, https://news.expats.cz/weekly-czec. [...] covid-19/.
77.
Face 2 Face Africa, Djibouti, others warned about chloroquine despite big COVID-19 recoveries, https://face2faceafrica.com/articl. [...] ecoveries.
78.
Faíco-Filho et al., Braz J Microbiol, doi:10.1007/s42770-020-00395-x (preprint 6/21), No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19, https://link.springer.com/article/1 [...] 0-00395-x.
79.
Falcone et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofaa563, Role of low-molecular weight heparin in hospitalized patients with SARS-CoV-2 pneumonia: a prospective observational study, https://academic.oup.com/ofid/adva. [...] 3/5992463.
80.
Ferreira et al., J. Medical Virology, July 9, 2020, doi:10.1002/jmv.26286 (preprint 6/29), Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection, https://onlinelibrary.wiley.com/doi [...] jmv.26286.
81.
Ferri at al., Clinical Rheumatology, doi:0.1007/s10067-020-05334-7, COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series, https://link.springer.com/article/1 [...] 0-05334-7.
82.
Filipova et al., Health Science Journal, Is there a Correlation between Changes in Hydroxychloroquine Use and Mortality Rates from COVID-19?, https://www.hsj.gr/medicine/is-the. [...] vid19.pdf.
83.
Fonseca et al., Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2020.101906, Risk of Hospitalization for Covid-19 Outpatients Treated with Various Drug Regimens in Brazil: Comparative Analysis, https://www.sciencedirect.com/scie. [...] 920304026.
84.
Fontana et al., Clinical Kidney Journal, 13:3, 334–339, doi:10.1093/ckj/sfaa084, SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience, https://academic.oup.com/ckj/article/13/3/334/5860798.
85.
France 24, Covid-19: In Cameroon, chloroquine therapy hailed by French expert becomes state protocol, https://www.france24.com/en/202005. [...] -protocol.
86.
France 24 (B), Covid-19 : au Cameroun, la méthode Raoult érigée en protocole d'État, https://www.france24.com/fr/202005. [...] %C3%A9tat.
87.
Franceinfo, Ces pays africains qui ont décidé de continuer à soigner le Covid-19 avec l'hydroxychloroquine, https://www.francetvinfo.fr/monde/. [...] 3239.html.
88.
Fried et al., Clinical Infectious Disease, doi:10.1093/cid/ciaa1268, Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States, https://academic.oup.com/cid/advan. [...] 8/5898276.
89.
Frontera et al., Research Square, doi:10.21203/rs.3.rs-94509/v1, Treatment with Zinc is Associated with Reduced In-Hospital Mortality Among COVID-19 Patients: A Multi-Center Cohort Study, https://www.researchsquare.com/article/rs-94509/v1.
90.
Gautret et al., Int. J. of Antimicrobial Agents, 17 March 2020, doi:10.1016/j.ijantimicag.2020.105949, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial, https://www.mediterranee-infection. [...] _IJAA.pdf.
91.
Geleris et al., NEJM, May 7, 2020, doi:10.1056/NEJMoa2012410, Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19, https://www.nejm.org/doi/full/10.1056/NEJMoa2012410.
92.
Gendebien et al., Annals of the Rheumatic Diseases, doi:10.1136/annrheumdis-2020-218244, Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments, https://ard.bmj.com/content/early/2 [...] 20-218244.
93.
Gendelman et al., Autoimmunity Reviews, 19:7, July 2020, doi:10.1016/j.autrev.2020.102566, Continuous Hydroxychloroquine or Colchicine Therapy Does Not Prevent Infection With SARS-CoV-2: Insights From a Large Healthcare Database Analysis, https://www.sciencedirect.com/scien [...] 220301282.
94.
Gentry et al., Lancet Rheumatology, doi:10.1016/S2665-9913(20)30305-2, Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study, https://www.thelancet.com/journals. [...] /fulltext.
95.
Gianfrancesco et al., Annals of the Rheumatic Diseases, 79:7, 859-866, doi:10.1136/annrheumdis-2020-217871, Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry, https://europepmc.org/article/med/32471903.
96.
Global Times, Chinese medical expert decorated by Djibouti for COVID-19 prevention, https://www.globaltimes.cn/content/1189839.shtml.
97.
Goenka et al., SSRN, doi:10.2139/ssrn.3689618, Seroprevalence of COVID-19 Amongst Health Care Workers in a Tertiary Care Hospital of a Metropolitan City from India, https://papers.ssrn.com/sol3/papers [...] d=3689618.
98.
Goldman et al., NEJM, doi:10.1056/NEJMoa2015301, Remdesivir for 5 or 10 Days in Patients with Severe Covid-19, https://www.nejm.org/doi/10.1056/NEJMoa2015301.
99.
Gonzalez et al., medRxiv, doi:10.1101/2020.08.18.20172874, The Prognostic Value of Eosinophil Recovery in COVID-19: A Multicentre, Retrospective Cohort Study on Patients Hospitalised in Spanish Hospitals, https://www.medrxiv.org/content/10. [...] 0172874v1.
100.
Government of China, 关于印发新型冠状病毒肺炎诊疗方案（试行第八版）的通知, http://www.nhc.gov.cn/yzygj/s7653p [...] e5a.shtml.
101.
Government of India, The caregiver and all close contacts of such cases should take HCQ prophylaxis, https://www.mohfw.gov.in/pdf/Revise [...] lines.pdf.
102.
Government of Venezuela, THERAPEUTIC MANAGEMENT GUIDE FOR COVID-19 PATIENTS AND CONTACTS, http://www.mpps.gob.ve/index.php/sistemas/descargas.
103.
Grau-Pujol et al., Research Square, doi:10.21203/rs.3.rs-72132/v1, Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: initial results of a double-blind, placebo-controlled randomized clinical trial, https://www.researchsquare.com/article/rs-72132/v1.
104.
Guérin et al., Asian J. Medicine and Health, July 15, 2020, doi:10.9734/ajmah/2020/v18i730224 (preprint 5/31), Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19, https://www.journalajmah.com/index. [...] iew/30224.
105.
Guisado-Vasco, Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort), https://www.sciencedirect.com/scien [...] 020303357.
106.
Guisado-Vasco (B), Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort), https://www.sciencedirect.com/scien [...] 020303357.
107.
GulfInsider, Coronavirus: Bahrain’s Therapeutic Medication Proved Effective, https://www.gulf-insider.com/coron. [...] ffective/.
108.
Gupta et al., JAMA Intern. Med., doi:10.1001/jamainternmed.2020.3596, Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US, https://jamanetwork.com/journals/j. [...] e/2768602.
109.
Heberto et al., IJC Heart & Vasculature, doi:10.1016/j.ijcha.2020.100638, Implications of myocardial injury in Mexican hospitalized patients with coronavirus disease 2019 (COVID-19), https://www.sciencedirect.com/scien [...] 720303365.
110.
Heras et al., European Geriatric Medicine, doi:10.1007/s41999-020-00432-w (preprint 9/2), COVID-19 mortality risk factors in older people in a long-term care center, https://link.springer.com/article/1 [...] 0-00432-w.
111.
Hong et al., Infect. Chemother., 2020, doi:10.3947/ic.2020.52.e43, Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication, https://icjournal.org/DOIx.php?id=1 [...] .52.3.396.
112.
Huang et al., Annals of the Rheumatic Diseases 2020:79, 1163-1169, doi:10.1136/annrheumdis-2020-217425, Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study, https://ard.bmj.com/content/79/9/1163.
113.
Huang (B) et al., National Science Review, nwaa113, doi:10.1093/nsr/nwaa113, Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19, https://academic.oup.com/nsr/advan. [...] 3/5848167.
114.
Huang (C) et al., Journal of Molecular Cell Biology, Volume 12, Issue 4, April 2020, 322–325, doi:10.1093/jmcb/mjaa014, Treating COVID-19 with Chloroquine, https://academic.oup.com/jmcb/article/12/4/322/5814655.
115.
Huang (D) et al., National Science Review, nwaa113, doi:10.1093/nsr/nwaa113, Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19, https://academic.oup.com/nsr/advan. [...] 3/5848167.
116.
Huh et al., medRxiv, doi:10.1101/2020.05.04.20089904, Association of previous medications with the risk of COVID-19: a nationwide claims-based study from South Korea, https://www.medrxiv.org/content/10. [...] 0089904v2.
117.
Ip et al., medRxiv, doi:10.1101/2020.08.20.20178772, Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: A multi-center observational study, https://www.medrxiv.org/content/10. [...] 0178772v1.
118.
Ip (B) et al., medRxiv, doi:10.1101/2020.05.21.20109207, Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients - An Observational Study, https://www.medrxiv.org/content/10. [...] 0109207v1.
119.
Izoulet M., SSRN, doi:10.2139/ssrn.3575899, Countries which Primarily Use Antimalarial Drugs As COVID-19 Treatment See Slower Dynamic of Daily Deaths, https://papers.ssrn.com/sol3/papers [...] d=3575899.
120.
Kamran et al., medRxiv, doi:10.1101/2020.07.30.20165365, Clearing the fog: Is HCQ effective in reducing COVID-19 progression: A randomized controlled trial, https://www.medrxiv.org/content/10. [...] 0165365v1.
121.
Kelly et al., British Journal of Clinical Pharmacology, doi:10.1111/bcp.14482, Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin, https://bpspubs.onlinelibrary.wiley [...] bcp.14482.
122.
Khurana et al., medRxiv, doi:10.1101/2020.07.21.20159301, Prevalence and clinical correlates of COVID-19 outbreak among healthcare workers in a tertiary level hospital, https://www.medrxiv.org/content/10. [...] 0159301v1.
123.
Kim et al., medRxiv, doi:10.1101/2020.05.13.20094193, Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea, https://www.medrxiv.org/content/10. [...] oned=true.
124.
Kirenga et al., BMJ Open Respiratory Research, doi:10.1136/bmjresp-2020-000646, Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda, https://bmjopenrespres.bmj.com/content/7/1/e000646.
125.
Komissarov et al., medRxiv, doi:10.1101/2020.06.30.20143289, Hydroxychloroquine has no effect on SARS-CoV-2 load in nasopharynx of patients with mild form of COVID-19, https://www.medrxiv.org/content/10. [...] 0143289v1.
126.
Konig et al., Annals of the Rheumatic Diseases, doi:10.1136/annrheumdis-2020-217690, Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19, https://ard.bmj.com/content/early/2 [...] 20-217690.
127.
Kuderer et al., Lancet, June 20, 2020, doi:10.1016/S0140-6736(20)31187-9 (preprint 5/28), Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, https://www.thelancet.com/journals. [...] /fulltext.
128.
Lagier et al., Travel Med. Infect. Dis. 101791, Jun 25, 2020, doi:10.1016/j.tmaid.2020.101791, Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, https://www.sciencedirect.com/scien [...] 920302817.
129.
Lambermont et al., Critical Care Explorations, doi:10.1097/CCE.0000000000000305, Predictors of Mortality and Effect of Drug Therapies in Mechanically Ventilated Patients With Coronavirus Disease 2019: A Multicenter Cohort Study, https://journals.lww.com/ccejourna. [...] g.10.aspx.
130.
Lammers et al., Int. J. Infectious Diseases, doi:10.1016/j.ijid.2020.09.1460, https://www.sciencedirect.com/scien [...] 220321755.
131.
Lano et al., Clinical Kidney Journal, 13:5, October 2020, 878–888, doi:10.1093/ckj/sfaa199, Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort, https://academic.oup.com/ckj/article/13/5/878/5934808.
132.
Laplana et al., medRxiv, doi:10.1101/2020.09.03.20158121, Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients, https://www.medrxiv.org/content/10. [...] 0158121v2.
133.
Lauriola et al., Clinical and Translational Science, doi:10.1111/cts.12860, Effect of combination therapy of hydroxychloroquine and azithromycin on mortality in COVID‐19 patients, https://ascpt.onlinelibrary.wiley.c [...] cts.12860.
134.
Le Nouvel Afrik, Covid-19 : pourquoi les Marocains décèdent plus en Europe qu’au Maroc, https://www.afrik.com/covid-19-pou. [...] -au-maroc.
135.
Lecronier et al., Critical Care, 24:418, 2020, doi:10.1186/s13054-020-03117-9, Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis, https://ccforum.biomedcentral.com/a [...] 0-03117-9.
136.
Lee et al., Arch Intern Med., 2011, 171:1, 18-22, doi:10.1001/archinternmed.2010.482, Analysis of Overall Level of Evidence Behind Infectious Diseases Society of America Practice Guidelines, https://jamanetwork.com/journals/j. [...] le/226373.
137.
LifeSiteNews, Doctors insist this cheap, safe drug is “key to preventing huge loss of life” from Wuhan virus, https://www.lifesitenews.com/news/. [...] vid-virus.
138.
Luo et al., Annals of Oncology, 31:10, 1386-1396, doi:10.1016/j.annonc.2020.06.007, COVID-19 in patients with lung cancer, https://www.annalsofoncology.org/a. [...] /fulltext.
139.
Ly et al., International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.106219 (preprint 8/21), Pattern of SARS-CoV-2 infection among dependant elderly residents living in retirement homes in Marseille, France, March-June 2020, https://www.sciencedirect.com/scie. [...] 920304301.
140.
Lyngbakken et al., Research Square, doi:10.21203/rs.3.rs-44055/v1, A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics, https://www.nature.com/articles/s41467-020-19056-6.
141.
Macias et al., medRxiv, 10.1101/2020.05.16.20104141, Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy, https://www.medrxiv.org/content/10. [...] 0104141v1.
142.
Magagnoli et al., Med (2020), doi:10.1016/j.medj.2020.06.001 (preprint 4/21), Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19, https://www.sciencedirect.com/scien [...] 020300064.
143.
Mahévas et al., BMJ 2020, 369, doi: https://doi.org/10.1136/bmj.m1844, Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data, https://www.bmj.com/content/369/bmj.m1844.
144.
Martinez-Lopez et al., , Multiple Myeloma and SARS-CoV-2 Infection: Clinical Characteristics and Prognostic Factors of Inpatient Mortality, https://www.medrxiv.org/content/10. [...] 0142455v1.
145.
Mathai et al., J. Marine Medical Society, doi:10.4103/jmms.jmms_115_20, Hydroxychloroquine as pre-exposure prophylaxis against COVID-19 in health-care workers: A single-center experience, https://www.marinemedicalsociety.in [...] id=300159.
146.
McGrail et al., medRxiv, doi:10.1101/2020.07.17.20156521, COVID-19 Case Series at UnityPoint Health St. Luke’s Hospital in Cedar Rapids, IA, https://www.medrxiv.org/content/10. [...] 0156521v1.
147.
McLean et al., Open Forum Infect. Dis. September 2015, 2:3, doi:10.1093/ofid/ofv100, Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525010/.
148.
Medical World Nigeria, Chloroquine potent for COVID-19 prevention, says NAFDAC, https://medicalworldnigeria.com/po. [...] pid=45479.
149.
Medical Xpress, Senegal says hydroxychloroquine virus treatment is promising, https://medicalxpress.com/news/202. [...] ment.html.
150.
Medical Xpress (B), Amid global controversy, Greece moves forward with chloroquine, https://medicalxpress.com/news/202. [...] uine.html.
151.
Membrillo de Novales et al., Preprints 2020, 2020050057, doi:10.20944/preprints202005.0057.v1, Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study, https://www.preprints.org/manuscript/202005.0057.
152.
Meneguesso, A., Médica defende tratamento precoce da Covid-19, https://www.youtube.com/watch?v=X5FCrIm_19U.
153.
Middle East Eye, Coronavirus: Turkey says hydroxychloroquine dramatically reduces pneumonia cases, https://www.middleeasteye.net/news. [...] -progress.
154.
Mikami et al., J. Gen. Intern. Med., doi:10.1007/s11606-020-05983-z, Risk Factors for Mortality in Patients with COVID-19 in New York City, https://link.springer.com/article/1 [...] 0-05983-z.
155.
Ministerstva Zdravotnictví, Rozhodnutí o dočasném povolení neregistrovaného humánního léčivého přípravku HYDROXYCHLOROQUINE SULFATE TABLETS, https://www.mzcr.cz/rozhodnuti-o-d. [...] -tablets/.
156.
Ministry of Health of Ukraine, ПРОТОКОЛ «НАДАННЯ МЕДИЧНОЇ ДОПОМОГИ ДЛЯ ЛІКУВАННЯ КОРОНАВІРУСНОЇ ХВОРОБИ (COVID-19)» , https://www.dec.gov.ua/wp-content/. [...] d19-f.pdf.
157.
Ministry of Health of Ukraine (B), «НАДАННЯ МЕДИЧНОЇ ДОПОМОГИ ДЛЯ ЛІКУВАННЯ КОРОНАВІРУСНОЇ ХВОРОБИ (COVID-19), https://moz.gov.ua/uploads/5/26129- [...] dod_1.pdf.
158.
Mitchell et al., SSRN, doi:10.2139/ssrn.3586954, Markedly Lower Rates of Coronavirus Infection and Fatality in Malaria-Endemic Regions – A Clue As to Treatment?, https://papers.ssrn.com/sol3/papers [...] d=3586954.
159.
Mitjà et al., NEJM, doi:10.1056/NEJMoa2021801 (preprint 7/26), A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease, https://www.nejm.org/doi/full/10.1056/NEJMoa2021801.
160.
Mitjà (B) et al., Clinical Infectious Diseases, ciaa1009, doi:10.1093/cid/ciaa1009, Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial, https://academic.oup.com/cid/articl [...] 9/5872589.
161.
Morocco World News, Moroccan Scientist: Morocco’s Chloroquine Success Reveals European Failures, https://www.moroccoworldnews.com/2. [...] failures/.
162.
Mosaique Guinee, Traitement des malades de covid19 en Guinée: « nous continuons avec l’hydroxychloroquine » (ANSS), https://mosaiqueguinee.com/traitem. [...] ine-anss/.
163.
Nachega et al., The American Journal of Tropical Medicine and Hygiene, doi:10.4269/ajtmh.20-1240, Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo, https://www.ajtmh.org/content/journ [...] h.20-1240.
164.
Ñamendys-Silva et al., Heart & Lung, doi:10.1016/j.hrtlng.2020.10.013, Outcomes of patients with COVID-19 in the Intensive Care Unit in Mexico: A multicenter observational study, https://www.sciencedirect.com/scien [...] 32030412X.
165.
Nichol et al., Injury, 2010, doi: 10.1016/j.injury.2010.03.033, Challenging issues in randomised controlled trials, https://www.injuryjournal.com/artic [...] /fulltext.
166.
Nigeria News World, COVID-19: Jigawa govt reveals secret behind mass recovery of patients, https://nigerianewsworld.com/news/. [...] patients/.
167.
NPR News, Senegal pledges a bed for every coronavirus patient, https://wfuv.org/content/senegal-p. [...] tacts-too.
168.
Núñez-Gil et al., Intern. Emerg. Med., doi:10.1007/s11739-020-02543-5, Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649104/.
169.
Omrani et al., EClinicalMedicine, doi:10.1016/j.eclinm.2020.100645, Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19, https://www.sciencedirect.com/scien [...] 020303898.
170.
Oneindia, No COVID-19 death in Manipur, Mizoram, Nagaland, Sikkim so far: Govt, https://www.oneindia.com/india/no-. [...] 1048.html.
171.
Paccoud et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaa791, Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital, https://academic.oup.com/cid/articl [...] 1/5859555.
172.
Pan African Medical Journal, Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study, https://www.panafrican-med-journal. [...] 1/9/full/.
173.
Parola et al., COVID-19 in Africa: What else?, https://www.mediterranee-infection. [...] OUMII.pdf.
174.
Peters et al., Clinical Microbiology and Infection, doi:10.1016/j.cmi.2020.10.004 (preprint 8/15), Outcomes of Persons With COVID-19 in Hospitals With and Without Standard Treatment With (Hydroxy)chloroquine, https://www.clinicalmicrobiologyan. [...] /fulltext.
175.
Pilot News, Chloroquine Can Treat Coronavirus at Early Stage – NAFDAC DG, https://www.westafricanpilotnews.c. [...] afdac-dg/.
176.
Pinato et al., Cancer Discovery, doi:10.1158/2159-8290.CD-20-0773, Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients, https://cancerdiscovery.aacrjourna. [...] D-20-0773.
177.
PledgeTimes, Russian Ministry of Health has updated recommendations for the treatment of COVID-19, https://pledgetimes.com/russian-mi. [...] covid-19/.
178.
Pleno.News, Cuba stands out in combating Covid with hydroxychloroquine, https://pleno.news/saude/coronavir. [...] uina.html.
179.
Polat et al., Medical Journal of Bakirkoy, 16:3, 280-6, doi:10.5222/BMJ.2020.50469, Hydroxychloroquine Use on Healthcare Workers Exposed to COVID-19 -A Pandemic Hospital Experience, https://www.bakirkoytip.org/jvi.as. [...] 69&look4=.
180.
Q Costa Rica, Hydroxychloroquine: The Drug Costa Rica Uses Successfully To Fight Covid-19, https://qcostarica.com/hydroxychlo. [...] covid-19/.
181.
Qin et al., Thrombosis Research, doi:10.1016/j.thromres.2020.11.020, Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era, https://www.sciencedirect.com/scien [...] 820306277.
182.
Rajasingham et al., medRxiv, doi:10.1101/2020.09.18.20197327, Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial, https://academic.oup.com/cid/advan. [...] 1/5929230.
183.
Rathi et al. Lancet Infect. Dis. doi:10.1016/S1473-3099(20)30313-3, Hydroxychloroquine prophylaxis for COVID-19 contacts in India, https://www.thelancet.com/journals. [...] /fulltext.
184.
RECOVERY Collaborative Group, NEJM, doi:10.1056/NEJMoa2022926 (press release 6/5), Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial, https://www.nejm.org/doi/full/10.1056/NEJMoa2022926.
185.
Rentsch et al., The Lancet Rheumatology, doi:10.1016/S2665-9913(20)30378-7 (preprint 9/9, https://www.medrxiv.org/content/10. [...] 0187781v1), Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform, https://www.sciencedirect.com/scien [...] 320303787.
186.
Revollo et al., Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkaa477, Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers, https://academic.oup.com/jac/advan. [...] 7/5997449.
187.
Rivera et al., Cancer Discovery, doi:10.1158/2159-8290.CD-20-0941, Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study, https://cancerdiscovery.aacrjourna. [...] D-20-0941.
188.
Rodriguez-Gonzalez et al., International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.106249, COVID-19 in hospitalized patients in Spain: a cohort study in Madrid, https://www.sciencedirect.com/scien [...] 920304696.
189.
Roomi et al., J. Medical Internet Research, doi:10.2196/21758, Efficacy of hydroxychloroquine and tocilizumab in patients with COVID-19: A single-center retrospective chart review, https://www.jmir.org/2020/9/e21758/.
190.
Rosenberg et al., JAMA, May 11, 2020, doi:10.1001/jama.2020.8630, Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State, https://jamanetwork.com/journals/ja [...] e/2766117.
191.
Russian Government, ВРЕМЕННЫЕ МЕТОДИЧЕСКИЕ РЕКОМЕНДАЦИИ ПРОФИЛАКТИКА, ДИАГНОСТИКА И ЛЕЧЕНИЕ НОВОЙ КОРОНАВИРУСНОЙ ИНФЕКЦИИ (COVID-19), https://static-0.minzdrav.gov.ru/s. [...] .9%29.pdf.
192.
Russian Government (B), Распоряжение Правительства Российской Федерации от 16.04.2020 № 1030-р, http://publication.pravo.gov.ru/Do [...] 037#print.
193.
Saleemi et al., medRxiv, doi:10.1101/2020.08.05.20151027, Time to negative PCR from symptom onset in COVID-19 patients on Hydroxychloroquine and Azithromycin - A real world experience, https://www.medrxiv.org/content/10. [...] 0151027v1.
194.
Sánchez-Álvarez et al., Nefrología, doi:10.1016/j.nefroe.2020.04.002, Status of SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN), https://www.sciencedirect.com/scien [...] 42030050X.
195.
Sbidian et al., medRxiv, doi:10.1101/2020.06.16.20132597, Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France, https://www.medrxiv.org/content/10. [...] 0132597v1.
196.
Self et al., JAMA, doi:10.1001/jama.2020.22240, Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial, https://jamanetwork.com/journals/ja [...] e/2772922.
197.
Serrano et al., Ann. Oncol., 2020, Sep, 31, S1026, doi:10.1016/j.annonc.2020.08.1830, COVID-19 and lung cancer: What do we know?, https://www.annalsofoncology.org/a. [...] /fulltext.
198.
Shabrawishi et al., medRxix, doi:10.1101/2020.05.08.20095679, Negative nasopharyngeal SARS-CoV-2 PCR conversion in response to different therapeutic interventions, https://www.medrxiv.org/content/10. [...] 0095679v1.
199.
Sheshah et al., Diabetes Research and Clinical Practice, doi:10.1016/j.diabres.2020.108538, Prevalence of Diabetes, Management and Outcomes among Covid-19 Adult Patients Admitted in a Specialized Tertiary Hospital in Riyadh, Saudi Arabia, https://www.sciencedirect.com/scien [...] 720307956.
200.
Shoaibi et al., medRxiv, doi:10.1101/2020.09.23.20199463, Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients, https://www.medrxiv.org/content/10. [...] 0199463v1.
201.
Simova et al., New Microbes and New Infections, doi:10.1016/j.nmni.2020.100813, Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health care workers, https://www.sciencedirect.com/scien [...] 520301657.
202.
Simova (B) et al., New Microbes and New Infections, doi:10.1016/j.nmni.2020.100813, Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health care workers, https://www.sciencedirect.com/scien [...] 520301657.
203.
Singer et al., Annals of the Rheumatic Diseases, doi:10.1136/annrheumdis-2020-218500, Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis, https://ard.bmj.com/content/early/2 [...] 20-218500.
204.
Singh et al., medRxiv, doi:10.1101/2020.05.12.20099028, Outcomes of Hydroxychloroquine Treatment Among Hospitalized COVID-19 Patients in the United States- Real-World Evidence From a Federated Electronic Medical Record Network, https://www.medrxiv.org/content/10. [...] 0099028v1.
205.
Skipper et al., Annals of Internal Medicine, doi:10.7326/M20-4207, Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial, https://www.acpjournals.org/doi/10.7326/M20-4207.
206.
Solh et al., medRxiv, doi:10.1101/2020.10.16.20214130, Clinical course and outcome of COVID-19 acute respiratory distress syndrome: data from a national repository, https://www.medrxiv.org/content/10. [...] 0214130v1.
207.
SOLIDARITY Trial Consortium, medRxiv, doi:10.1101/2020.10.15.20209817, Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results, https://www.medrxiv.org/content/10. [...] 0209817v1.
208.
Soto-Becerra et al., medRxiv, doi:10.1101/2020.10.06.20208066, Real-World Effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: Results of a target trial emulation using observational data from a nationwide Healthcare System in Peru, https://www.medrxiv.org/content/10. [...] 0208066v1.
209.
Sulaiman et al., medRxiv, doi:10.1101/2020.09.09.20184143, The Effect of Early Hydroxychloroquine-based Therapy in COVID-19 Patients in Ambulatory Care Settings: A Nationwide Prospective Cohort Study, https://www.medrxiv.org/content/10. [...] 0184143v1.
210.
Synolaki et al., medRxiv, doi:10.1101/2020.09.05.20184655, The Activin/Follistatin-axis is severely deregulated in COVID-19 and independently associated with in-hospital mortality, https://www.medrxiv.org/content/10. [...] 0184655v2.
211.
Tang et al., BMJ 2020, 369, doi:10.1136/bmj.m1849, Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial, https://www.bmj.com/content/369/bmj.m1849.
212.
Tehrani et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2020.10.071, Risk factors for mortality in adult COVID-19 patients; frailty predicts fatal outcome in older patients, https://www.sciencedirect.com/scien [...] 220322761.
213.
Teller Report, Coronavirus: a study in Senegal confirms the effectiveness of hydroxychloroquine, http://www.tellerreport.com/news/2 [...] Kst8.html.
214.
The Africa Report, Coronavirus: Didier Raoult the African and chloroquine, from Dakar to Brazzaville, https://www.theafricareport.com/26. [...] zzaville/.
215.
The Australian, India and Indonesia stand by antimalarials, https://www.theaustralian.com.au/w. [...] 9d7f1f97c.
216.
The BL, Russia supports the use of hydroxychloroquine, the drug to treat the CCP Virus suggested by Trump, https://thebl.com/world-news/russi. [...] rump.html.
217.
The East African, Algeria backs use of malaria drug despite WHO dropping trials, https://www.theeastafrican.co.ke/n. [...] ndex.html.
218.
The Guardian, Chloroquine potent for COVID-19 prevention, says NAFDAC, https://guardian.ng/news/nigeria/n. [...] s-nafdac/.
219.
The Indian Express, Vadodara administration drive: HCQ helping in containing Covid-19 cases, say docs as analysis begins, https://indianexpress.com/article/. [...] -6486049/.
220.
The Moscow Times, Russia Approves Unproven Malaria Drug to Treat Coronavirus, https://www.themoscowtimes.com/202. [...] us-a70025.
221.
The New York Times, Malaria Drug Taken by Trump Is Tied to Increased Risk of Heart Problems and Death in New Study, https://www.nytimes.com/2020/05/22. [...] irus.html.
222.
The New York Times (B), Small Chloroquine Study Halted Over Risk of Fatal Heart Complications, https://www.nytimes.com/2020/04/12. [...] =em-share.
223.
The New York Times (C), Malaria Drug Promoted by Trump Did Not Prevent Covid Infections, Study Finds, https://www.nytimes.com/2020/06/03. [...] rump.html.
224.
The New York Times (D), Coronavirus Can Be Deadly for Young Adults, Too, Study Finds, https://www.nytimes.com/2020/09/10/ [...] irus.html.
225.
The North Africa Post, Morocco continues use of Chloroquine despite controversy, https://northafricapost.com/41247-. [...] ersy.html.
226.
The Tico Times, News briefs: Reopening plans on-track, hydroxychloroquine use to continue, partnership with Coursera, https://ticotimes.net/2020/06/15/n. [...] -coursera.
227.
Treanor et al., JAMA, 2000, 283:8, 1016-1024, doi:10.1001/jama.283.8.1016, Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza: A Randomized Controlled Trial, https://jamanetwork.com/journals/ja [...] le/192425.
228.
Trullàs et al., Research Square, doi:10.21203/rs.3.rs-39421/v1 , High in-hospital mortality due to COVID-19 in a community hospital in Spain: a prospective observational study, https://www.researchsquare.com/article/rs-39421/v1.
229.
Ukrinform, Ukraine receives batch of hydroxychloroquine tablets from India, https://www.ukrinform.net/rubric-e. [...] ne-3.html.
230.
Ulrich et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofaa446, Treating Covid-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind, Randomized Controlled Trial in Hospitalized Patients, https://academic.oup.com/ofid/adva. [...] 6/5910201.
231.
United States National Institutes of Health, Chloroquine or Hydroxychloroquine With or Without Azithromycin, https://www.covid19treatmentguidel. [...] hromycin/.
232.
van Halem et al., BMC Infect Dis., doi:10.1186/s12879-020-05605-3, Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691970/.
233.
Vanguard, COVID-19: Nigerian study finds Chloroquine, Hydroxychloroquine effective as Prophylaxis, https://www.vanguardngr.com/2020/0. [...] phylaxis/.
234.
Voice of America, Cameroon Begins Large-scale Chloroquine Production, https://www.voanews.com/science-he. [...] roduction.
235.
Wang et al., medRxiv, doi:10.1101/2020.06.11.20128926, Comorbidity and Sociodemographic determinants in COVID-19 Mortality in an US Urban Healthcare System, https://www.medrxiv.org/content/10. [...] 0128926v1.
236.
Xia et al., ChiCTR2000029741, Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study, http://www.chictr.org.cn/showproj.aspx?proj=49263.
237.
Yu et al., Science China Life Sciences, 2020 May 15, 1-7, doi:10.1007/s11427-020-1732-2, Low Dose of Hydroxychloroquine Reduces Fatality of Critically Ill Patients With COVID-19, https://pubmed.ncbi.nlm.nih.gov/32418114/.
238.
Zhang et al., JAMA, 80:19, 1690, doi:10.1001/jama.280.19.1690, What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes, https://jamanetwork.com/journals/ja [...] le/188182.
239.
Zhong et al., Lancent Rheumatology, 10.1016/S2665-9913(20)30227-7, COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study, https://www.thelancet.com/journals. [...] /fulltext.
240.
Zhong (B) Nanshan (钟南山), Efficacy and safety of chloroquine for treatment of COVID-19. An open-label, multi-center, non-randomized trial, https://twitter.com/JamesTodaroMD/s [...] 944480265.

 

Oui , je sais t'es fort pour traiter de charlatans tous ceux qui vont ps dans ton sens.. :o

 

J'ai cliqué sur 5 liens au hasard.
4 pages introuvables et une sur le fait que l'âge moyen des 452 décès de Ciudad Real avaient 80.43 ans. Aucune référence à la HCQ.
Les liens twitter sont inutiles car pas des revues médicales spécialisées reconnues.

Message cité 2 fois

---------------
Quercy powaa ^^
n°61518744
Balec
Posté le 04-12-2020 à 20:03:31  profilanswer
 

AzR3L a écrit :


 
CE qui me sidère le plus, c'est j'ai peur du COVID, mais encore plus du VACCIN.. MA grand mère qui a un cancer donc logiquement à fort risque et qui va reprendre sa chimio  :( , ne veut pas se faire vacciner.. :pfff:  car elle a peur des  conséquences potentielles du VACCIN


Elle a raison puisqu'on ne connait pas les conséquences de ces vaccins. Aucune publication scientifique.

Message cité 1 fois
n°61518746
sausalito7​5
Posté le 04-12-2020 à 20:03:38  profilanswer
 

boumbo a écrit :

[:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]  [:lafroussedanstonfrog:3]
 
j’ai fait une sausalito :o


T'as bien fait de l'écrire, j'avais même pas vu  :lol:  :lol:

n°61518752
boumbo
3xpl0its
Posté le 04-12-2020 à 20:04:55  profilanswer
 

Vous ne pouvez pas :
- soit ne pas répondre à ce pavé de m...
- soit virer les liens quand vous répondez ?  
 
:o

Message cité 2 fois
n°61518753
Killall-9
+on&2foo...
Posté le 04-12-2020 à 20:04:57  profilanswer
 

Tolor a écrit :

[:soulafa] Comme chaque soir, les chiffres du jour pour la France, avec les données de sante publique France :
 
Hôpitaux
Décès : 284 (hier : 326 / J-7 : 396 / moyenne sur 7j de 301)
Réa : 165 (hier : 184 / J-7 : 206 / moyenne sur 7j de 166, Rt de 0,8)
Hospitalisés : 1 400 (hier : 1 450 / J-7 : 1 471 / moyenne sur 7j de 1 223, Rt de 0,88)
Total réa : 3 283 (hier : 3 415 / J-7 : 3 871) soit une baisse de 132
Total hospitalisation : 26 283 (hier : 26 675 / J-7 : 28 620) soit une baisse de 392
 
Baisse assez importante des totaux. Les Rt augmentent encore un peu (+0,01 pour les réa, +0,03 pour les hospi
On devrait passer la barre des 3000 mardi ou mercredi prochain
 
Pour les chiffres régionaux, ça stagne un peu au niveau des hospi, ça baisse au niveau réa et décès
https://i.imgur.com/fTeRIjB.png
 
Concernant l'occupation en réa, Martinique et Corse montent respectivement de 2 et 1
https://i.imgur.com/9KXth8P.png
 
Tests
Ajout des chiffres du mercredi 1er décembre, le Rt augmente à nouveau et repasse les 0,8. L'incidence et la positivité baisse
Si on continue comme ça, l'objectif des 5k ne sera pas atteint le 15
https://i.imgur.com/rfq2ag9.png
 
Pour les régions,
https://i.imgur.com/09zInSz.png
 
Et les départements, 11 départements sont au-dessus de 1
https://i.imgur.com/ThWuEQU.png
 
Passage aux urgences
Le Rt remonte à 0,85
 
Rt
https://i.imgur.com/QadLchZ.png
 
#SUIVICOVID


Bon, plus trop de doutes qu'on est en phase ascendante, lô...  [:killall-9]

n°61518765
Requiem
Posté le 04-12-2020 à 20:06:13  profilanswer
 

fred_div91 a écrit :


 
T'es pas obligé de rester en France hein ... Le monde est vaste.


 
J'y reste volontiers parce que c'est un formidable pays. Peuplé de mecs jamais contents et de mecs qui ne saississent ni l'importance de la nuance ni celle de la remise en question dès que ça sort des sentiers battus. Mais j'aime mon pays. Même s'il est parfois peuplé d'abrutis qui disent "réfléchir" mais qui ne réfléchissent que vers les affirmations qui vont dans leur sens.

Message cité 1 fois

---------------
GDB power
n°61518772
AzR3L
Posté le 04-12-2020 à 20:06:43  profilanswer
 

Balec a écrit :


Elle a raison puisqu'on ne connait pas les conséquences de ces vaccins. Aucune publication scientifique.


 
SI je reprend ton argumentation, rien ne dit qu'elle aura des conséquences comme il n'y a eu aucune publication scientifique

Message cité 1 fois
n°61518779
krosso
j'suis à la bourre
Posté le 04-12-2020 à 20:07:59  profilanswer
 

Ernestor a écrit :


Pays d'idiots [:fever pitch:10]


Un autre symptôme de notre profond problème d'éducation.


---------------
Dieu se rit des hommes qui déplorent les effets dont ils chérissent les causes.
n°61518785
krosso
j'suis à la bourre
Posté le 04-12-2020 à 20:08:53  profilanswer
 

[Toine] a écrit :


Non. Si vraiment les français étaient si réfractaires et méfiants à la médecine, on n'aurait pas une des meilleure espérance de vie au monde.
 
Après oui, le Français a tendance à ne pas croire sur parole, il exige des preuve et n'aime pas les arguments d'autorité.


On vit sur nos acquis.
On en reparle dans 20 ans ?


---------------
Dieu se rit des hommes qui déplorent les effets dont ils chérissent les causes.
n°61518791
epsiloneri​dani
Posté le 04-12-2020 à 20:10:01  profilanswer
 

epsiloncentaury a écrit :


 
VIDEO-Is hydroxychloroquine effective for COVID-19? A video history of the 152 HCQ studies to date
 
 
Oui , je sais t'es fort pour traiter de charlatans tous ceux qui vont ps dans ton sens..  :o  


 
C'est bien de mettre une biblio à rallonge pour impressionner. Sauf que dans le tas il y a plein de trucs aussi pertinents que Pif-Gadget, il y a des liens anti-HCQ. Je t'aurais fait un copier-coller de pubmed ça aurait été à peu près aussi intéressant. Enfin, plus intéressant parce que ça aurait éliminé tout ce qui n'a rien de scientifique.

n°61518793
La Monne
Tu dois rompre.
Posté le 04-12-2020 à 20:10:08  profilanswer
 

boumbo a écrit :

Vous ne pouvez pas :
- soit ne pas répondre à ce pavé de m...
- soit virer les liens quand vous répondez ?

 

:o


+1
je vais TT les prochains

Message cité 1 fois

---------------
Lu et approuvé.
n°61518796
Balec
Posté le 04-12-2020 à 20:10:22  profilanswer
 

AzR3L a écrit :


 
SI je reprend ton argumentation, rien ne dit qu'elle aura des conséquences comme il n'y a eu aucune publication scientifique


Libre à toi d'essayer. ;)

Message cité 1 fois
n°61518797
daouar
Shree Uvasaggaharam Stotra
Posté le 04-12-2020 à 20:10:44  profilanswer
 


 
Qui a gâché le plus de recherche publique, Raoult ou le Remdesivir ? Je pose calmement la question, la réponse n'est pas simple...
 
Il fallait tester sérieusement l'HCQ, comme le Remdesivir, surtout qu'en France on aime bien refaire ce qui est déjà fait. Résultat, aucun des deux ne fonctionne.

Message cité 1 fois

---------------
Ducouïte : maladie consistant à parsemer ses posts de "du coup" et "pour le coup" | TU des moteurs de recherche !
mood
Publicité
Posté le   profilanswer
 

 Page :   1  2  3  4  5  ..  12741  12742  12743  ..  25261  25262  25263  25264  25265  25266
Page Suivante
Page Précédente
Haut de page 

Aller à :
Ajouter une réponse
 

Sujets relatifs
Mr Flex - Retour en France - voyage terminéNouveau téléphone fixe origine japonais (anti pub)
Greater China: 1 country 4 countries (ou bientôt 3 :o)Football féminin : Équipe de Rance
Petit nouveau et urbexLes maillots de football NOUVEAU: PSG, PORTUGAL, AMERICA...
Aliexpress - La chine a des soucis ?Idée de nouveau régime : le régime mixte
Nouveau compte paypal, virement reçu bloqué!le monde merveilleux de chronopost :)
Plus de sujets relatifs à : COVID-19 - sa vie, son œuvre

Forum MesDiscussions.Net, Version 2010.2
(c) 2000-2011 Doctissimo
Page générée en 0.172 secondes

Copyright © 1997-2025 Groupe LDLC (Signaler un contenu illicite / Données personnelles)